Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 10 · below the Ichimoku cloud · RSI 33 · MACD below its signal · 1% above its 52-week low
None of the 29 investors followed here reported a position in PRFX in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a PRFX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No analyst coverage for this instrument.
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
No insider transactions reported for PRFX.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.0 | -13.5 | -31.8 | -4.7 | 55.4 | -54.0 | -27.5 | -4.6 | -0.4 | -13.9 | −74.5% | ||
| 2025 | -7.0 | 1.0 | -31.4 | 12.0 | -20.2 | -25.4 | -0.7 | 1.4 | -3.4 | -11.4 | -22.2 | -33.5 | −80.9% |
| 2024 | -27.3 | -5.0 | -4.2 | -49.2 | -23.2 | -32.4 | -15.6 | -44.9 | -53.8 | -19.1 | 456.0 | 20.7 | −79.7% |
| 2023 | 21.1 | 25.0 | 10.4 | -18.1 | -18.6 | 19.3 | 28.1 | -32.1 | -27.0 | -37.6 | 15.2 | 10.0 | −33.4% |
| 2022 | -17.3 | -8.2 | 22.8 | -24.3 | -4.2 | 5.3 | -25.1 | -6.3 | 3.8 | -13.0 | -25.8 | -7.2 | −68.9% |
| 2021 | 1.1 | 43.6 | -31.9 | -28.5 | -5.1 | -6.0 | 2.1 | 2.4 | -6.1 | -15.2 | -23.8 | -25.7 | −70.2% |
| 2020 | -0.2 | 5.2 | -7.5 | −2.8% |